Royalty Pharma plc Class A Ordinary Shares (RPRX) Financials
Key financial figures for Royalty Pharma plc Class A Ordinary Shares (Q2 2026).
Royalty Pharma plc reported revenue of $674.1 million for Q2 FY2026, up 16.5% from the same period a year earlier. Net income was $17.9 million, or $0.04 per share. Operating margin came to 19.73%, against 36.26% a year earlier. Free cash flow for the period was $686.2 million. Across the last 5 reported quarters, quarterly revenue has risen from $578.7 million in Q2 FY2025 to $674.1 million in Q2 FY2026. The figures above are as filed, and the full income statement, balance sheet and cash flow history for Royalty Pharma plc are on the SentiSense financials page.
- Revenue
- $674M
- Net Income
- $18M
- EPS
- $0.04
- Total Assets
- $19.8B
- Operating Cash Flow
- $686M
Recent quarters
| Period | Revenue | Net Income | EPS | Operating Margin | Free Cash Flow |
|---|---|---|---|---|---|
| Q2 FY2026 | $674M | $18M | $0.04 | 19.73% | $686M |
| Q1 FY2026 | $631M | $295M | $0.53 | 100.3% | $761M |
| Q4 FY2025 | $622M | $214M | $0.50 | 62.44% | $827M |
| Q3 FY2025 | $609M | $288M | $0.67 | 70.11% | $703M |
| Q2 FY2025 | $579M | $30M | $0.07 | 36.26% | $364M |
Recent fiscal years
| Period | Revenue | Net Income | EPS | Operating Margin | Free Cash Flow |
|---|---|---|---|---|---|
| FY2025 | $2.4B | $771M | $1.80 | 65.58% | $2.5B |
| FY2024 | $2.3B | $859M | $1.91 | 57.1% | $2.8B |
| FY2023 | $2.4B | $1.1B | $2.53 | 63.37% | $3.0B |
Frequently asked questions
What was Royalty Pharma plc's revenue last quarter?
Royalty Pharma plc reported revenue of $674.1 million for Q2 FY2026, up 16.5% from the same period a year earlier.
Is Royalty Pharma plc profitable?
Yes. Royalty Pharma plc reported net income of $17.9 million for Q2 FY2026, a net margin of 2.65% on revenue.
How has Royalty Pharma plc's margin trended?
Operating margin was 19.73% in Q2 FY2026, compared with 36.26% in the same period a year earlier. The quarter by quarter series is on the SentiSense financials page.
How much free cash flow did Royalty Pharma plc generate?
Royalty Pharma plc generated free cash flow of $686.2 million in Q2 FY2026, after capital expenditure.
Full income statement, balance sheet and cash flow for Royalty Pharma plc Class A Ordinary Shares on SentiSense, with up to forty quarters and twenty fiscal years of history.